Aurora O’Brate

35 papers receiving 2.0k citations

Aurora O’Brate's Hit Papers

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial 2024 · 64 citations
640+1Years since publication204060

Peers

Aurora O’Brate
Comparison fields: 5 of 64
  • Cell Biology 334
  • Organic Chemistry 280
  • Pulmonary and Respiratory Medicine 245
  • Oncology 147
  • Cancer Research 66
Replace Byron H. Long with:
Byron H. Long United States
Michael D. Kaufman United States
Aaron Balog United States
Yi‐He Ling United States
Carolyn M. Discafani United States
Michelandrea De Cesare Italy
Paolo Cappella Italy
Patrick Dumont Belgium
Arturo P. Galvani Italy
Lusong Luo China
Aurora O’Brate relative to Byron H. Long United States Byron H. Long's profile →
Citations per field
00.5×2×4×5.9×
Byron H. Long · 1×
Citations per year

Countries citing papers authored by Aurora O’Brate

Since Specialization
Citations

This map shows the geographic impact of Aurora O’Brate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurora O’Brate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurora O’Brate more than expected).

Fields of papers citing papers by Aurora O’Brate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurora O’Brate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurora O’Brate. The network helps show where Aurora O’Brate may publish in the future.

Co-authors

The 25 scholars most cited alongside Aurora O’Brate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aurora O’Brate Line = papers co-authored together Aurora O’Brate links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999250
2 2002217
3 2003180
4 2002178
5 2004152
6 2004107
7 200597
8 200385
9 201180
10 202379
11 200378
12 200564
13 201264
14
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
Hit paper breakdown →
202464
15 200457
16 200356
17 200248
18 200442
19 200637
20 200435

About Aurora O’Brate

Aurora O’Brate is a scholar working on Cell Biology, Pulmonary and Respiratory Medicine, Cancer Research, Organic Chemistry and Hepatology, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Microtubule and mitosis dynamics (7 papers), Synthesis and biological activity (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Advanced Synthetic Organic Chemistry (1 paper), Cancer Genomics and Diagnostics (1 paper), Microbial Natural Products and Biosynthesis (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Cell Biology (334 citations), Organic Chemistry (280 citations), Pulmonary and Respiratory Medicine (245 citations), Oncology (147 citations) and Cancer Research (66 citations). Aurora O’Brate has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Paraskevi Giannakakou, Kyriacos Costa Nicolaou, José M. Andreu, Rafael Rosell, José Fernando Díaz, Marisa Carbonaro, Ernest Hamel, Mariano Monzó, Mali Venkat Reddy and Rubén M. Buey. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research, Current Opinion in Oncology, Lung Cancer and Drug Resistance Updates.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact